PhoRTE® Therapy Efficacy: In-Person Versus Telehealth
Launched by UNIVERSITY OF SOUTHERN CALIFORNIA · Apr 10, 2025
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how effective a voice therapy called PhoRTE® is when delivered in-person compared to through telehealth (video calls) for older adults who have voice problems related to aging. The goal is to find out if online therapy can be just as helpful as face-to-face therapy, making it easier and more affordable for seniors to get treatment for issues like hoarseness or changes in their voice.
To participate, you need to be at least 55 years old and have specific voice changes due to aging. You’ll have to have a device with a camera and microphone for telehealth sessions and be able to attend four sessions, either online or in-person. Participants will be involved in four 45-minute therapy sessions, and researchers will measure improvements in voice function and overall satisfaction after treatment. This trial aims to see if telehealth can be a good alternative to traditional therapy, especially as healthcare options are changing.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Adults 55+ with a primary diagnosis of presbyphonia, age-related voice changes, and/or vocal fold atrophy with or without localized loss of lamina propria (e.g. vocal fold scar)
- • Telehealth-capable device (e.g., tablet, computer) with microphone, speaker, camera, high-speed internet
- • Ability to attend four telehealth or in-person sessions for four consecutive sessions
- • Ability to attend two in-person evaluation sessions (pre- and post-treatment)
- Exclusion Criteria:
- • Presence of localized masses, lesions, or vocal fold motion impairments identified during videostroboscopy at initial evaluation
- • Progressive neurologic conditions, e.g. Parkinson's disease (PD), Amyotrophic lateral sclerosis (ALS), Progressive supranuclear palsy (PSP), etc.
- • Previous attendance to exuberant voice therapy (e.g., PhoRTE, Lee Silverman Voice Treatment)
- • Untreated hearing loss
- • Non-English speakers
About University Of Southern California
The University of Southern California (USC) is a prestigious research institution located in Los Angeles, California, known for its commitment to advancing knowledge and innovation in various fields, including medicine and health sciences. As a clinical trial sponsor, USC leverages its extensive resources, interdisciplinary expertise, and state-of-the-art facilities to conduct cutting-edge research aimed at improving patient outcomes and public health. The university fosters collaboration among its diverse faculty and students, ensuring a dynamic environment for the development and implementation of clinical studies that adhere to the highest ethical and scientific standards. Through its clinical trials, USC aims to contribute to the advancement of medical science and the translation of research findings into practical applications that benefit communities locally and globally.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Arcadia, California, United States
Beverly Hills, California, United States
Glendale, California, United States
Los Angeles, California, United States
Patients applied
Trial Officials
Aaron Rothbart, PhD
Principal Investigator
University of Southern California
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported